Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy

Creative Commons License

Agacdiken A., Celikyurt U., ŞAHİN T., KARAÜZÜM K., VURAL A., Ural D.

MEDICAL SCIENCE MONITOR, cilt.19, ss.373-377, 2013 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19
  • Basım Tarihi: 2013
  • Doi Numarası: 10.12659/msm.883915
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.373-377
  • Anahtar Kelimeler: cardiac resynchronization therapy, heart failure, neutrophil, lymphocyte, C-REACTIVE PROTEIN, HEART-FAILURE, MYOCARDIAL-INFARCTION, IMPROVEMENT, MORTALITY, SELECTION, CRT
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Background: Neutrophil-to-lymphocyte (N/L) ratio has been associated with adverse outcomes in patients with acute coronary syndromes and increased risk for long-term mortality in patients with acute decompensated heart failure. We aimed to investigate the prognostic value of neutrophil-to-lymphocyte ratio on response to cardiac resynchronization therapy (CRT).